Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Spruce, WE"'
Autor:
Stephen J. Forman, Robert B. Rosen, Spruce We, Robert A. Krance, KG Blume, Thomas Hecht, WP Hammond
Publikováno v:
Blood. 60:1263-1266
Human cyclic neutropenia shows many features in common with the animal model of cyclic neutropenia in grey collie dogs. Until now, however, evidence was lacking that cyclic neutropenia in man as in the dog is caused by a defect in a transplantable he
Autor:
Edward P. Scott, Spruce We, Thomas Hecht, Stephen J. Forman, Fahey Jl, Karl G. Blume, Farbstein Mj, John A. Zaia, Auayporn Nademanee, Robert A. Krance, Jeffrey L. Wolf, David O. Findley
Publikováno v:
Blood. 61:439-442
Of 33 patients who had undergone allogeneic bone marrow transplantation during first complete remission of acute nonlymphocytic leukemia, 21 patients have now been followed in continued complete remission for 6- 64 mo (median greater than 18 mo) with
Autor:
Karl G. Blume, G M Schmidt, Bross Kj, Jeffrey L. Wolf, Fahey Jl, Ram K. Chillar, Ernest Beutler, Mark A. Turner, Edward P. Scott, Stephen J. Forman, Farbstein Mj, Spruce We, Ellington Ob
Publikováno v:
New England Journal of Medicine. 302:1041-1046
Thirty-three patients with acute leukemia (15 with lymphoblastic leukemia and 18 with myeloblastic leukemia) were entered into a program of high-dose radiochemotherapy followed by allogeneic bone-marrow transplantation. These patients were in various
Autor:
Spruce We, Robert A. Krance, Lawrence D. Petz, Keith Beddow, Jill Hows, Donald R. Branch, Irena Sniecinski, Edward Gordon-Smith
Publikováno v:
Blood. 67:177-181
Six cases of immune hemolytic anemia attributed to donor-derived red cell antibodies after allogeneic bone marrow transplantation (BMT) are reported. In 2/6 cases, severe intravascular hemolysis was seen, 6/6 required increased red cell transfusion,
Autor:
Edward P. Scott, Karl G. Blume, Jeffrey L. Wolf, Henry Rappaport, Fahey Jl, Stephen J. Forman, Robert M. Bearman, Spruce We, Farbstein Mj
Publikováno v:
Blood. 59:191-193
A 28-yr-old woman with acute malignant myelosclerosis received, as primary treatment, ablative chemotherapy and total body radiation therapy followed by bone marrow transplantation from her histocompatible brother. The patient is now well more than 1
Publikováno v:
Blut. 38:135-137
Lymphocyte phosphoglucomutase can be used as a genetic marker to document successful engraftment in bone marrow transplant recipients. Two patients who underwent marrow transplantation as a treatment for acute leukemia showed a change into donor-type
Publikováno v:
Transplantation. 35:638-640
Autor:
Spruce We, Jeffrey L. Wolf, Stephen J. Forman, Farbstein Mj, Edward P. Scott, Karl G. Blume, Fahey Jl
Publikováno v:
New England Journal of Medicine. 305:101-103
Autor:
Forman, SJ, Spruce, WE, Farbstein, MJ, Wolf, JL, Scott, EP, Nademanee, AP, Fahey, JL, Hecht, T, Zaia, JA, Krance, RA, Findley, DO, Blume, KG
Publikováno v:
Blood; March 1983, Vol. 61 Issue: 3 p439-442, 4p
Publikováno v:
Blood; December 1982, Vol. 60 Issue: 6 p1263-1266, 4p